Valeant Pharmaceuticals International News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.04.18	Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting (PR Newswire)
19.04.18	Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program (PR Newswire)
19.04.18	Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program (PR Newswire)
12.04.18	Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due 2020 (PR Newswire)
12.04.18	Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due 2020 (PR Newswire)
11.04.18	Bausch + Lomb to Showcase New Scientific Data During the Annual Meeting of the American Society of Cataract and Refractive Surgery (PR Newswire)
11.04.18	Bausch + Lomb to Showcase New Scientific Data During the Annual Meeting of the American Society of Cataract and Refractive Surgery (PR Newswire)
11.04.18	Valeant And One Of Its Subsidiaries Announce Expiration And Final Settlement Date For Cash Tender Offers For Senior Notes (PR Newswire)
11.04.18	Valeant And One Of Its Subsidiaries Announce Expiration And Final Settlement Date For Cash Tender Offers For Senior Notes (PR Newswire)
09.04.18	Ortho Dermatologics: DUOBRII Shows Superiority Over Vehicle In Two Weeks (RTTNews)
09.04.18	Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII™ In The Journal of the American Academy of Dermatology (PR Newswire)
09.04.18	Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII™ In The Journal of the American Academy of Dermatology (PR Newswire)
06.04.18	Valeant Will Release First-Quarter 2018 Financial Results On May 8 (PR Newswire)
06.04.18	Valeant Will Release First-Quarter 2018 Financial Results On May 8 (PR Newswire)
05.04.18	Brigham families will be able to enjoy improved community spaces for a better quality of life (PR Newswire)
03.04.18	Salix Launches 'Let's Talk 2' IBS Awareness Campaign (PR Newswire)
03.04.18	Salix Launches 'Let's Talk 2' IBS Awareness Campaign (PR Newswire)
28.03.18	Microsemi's Leadership in Space Continues with Class V and Q Qualifications and QML Certification for its Radiation-Tolerant Eight-Channel Source Driver, Now in Production (PR Newswire)
26.03.18	Valeant and One of its Subsidiaries Announce Early Tender Results and Early Settlement Date for Cash Tender Offers for Senior Notes (PR Newswire)
26.03.18	Valeant and One of its Subsidiaries Announce Early Tender Results and Early Settlement Date for Cash Tender Offers for Senior Notes (PR Newswire)
19.03.18	ShangPharma Innovation Expands Incubator to Drive Life Science Innovation in Bay Area (PR Newswire)
13.03.18	Valeant And One Of Its Subsidiaries Announce Upsize Of Cash Tender Offers To $1,500,000,000 Outstanding Principal Amount (PR Newswire)
13.03.18	Valeant And One Of Its Subsidiaries Announce Upsize Of Cash Tender Offers To $1,500,000,000 Outstanding Principal Amount (PR Newswire)
12.03.18	TTEC Announces Fourth Quarter and Full Year 2017 Financial Results (PR Newswire)
08.03.18	Valeant To Participate At The 2018 Barclays Global Healthcare Conference (PR Newswire)
08.03.18	Valeant To Participate At The 2018 Barclays Global Healthcare Conference (PR Newswire)
01.03.18	CEO of eFatoora Dubai and Success in the GCC (PR Newswire)
01.03.18	ZSAN Implodes, ACAD Sees Sales Growth, VRX Paints A Not So Rosy Picture (RTTNews)
28.02.18	Valeant Pharma Turns To Profit In Q4, But Revenues Miss View (RTTNews)
28.02.18	Valeant Announces Fourth-Quarter And Full-Year 2017 Results And Provides 2018 Guidance (PR Newswire)
28.02.18	Valeant Announces Fourth-Quarter And Full-Year 2017 Results And Provides 2018 Guidance (PR Newswire)
28.02.18	Mark Your Calendar For CDTX Data, VRX Inks Deal, VTVT On STRADFAST Watch (RTTNews)
28.02.18	Valeant Announces Licensing Agreement With Kaken Pharmaceutical Co., Ltd. To Develop And Commercialize New Chemical Entity For Psoriasis (PR Newswire)
28.02.18	Valeant Announces Licensing Agreement With Kaken Pharmaceutical Co., Ltd. To Develop And Commercialize New Chemical Entity For Psoriasis (PR Newswire)
26.02.18	/R E P R I S E -- Invitation aux médias - Annonce concernant le renforcement des services de première ligne/ (PR Newswire)
23.02.18	Federated Investors, Inc. Files Annual Report on Form 10-K with U.S. Securities and Exchange Commission (PR Newswire)
16.02.18	Ortho Dermatologics Presents An Analysis Of SILIQ™ (Brodalumab) Injection Phase 3 Data On Disease-Related Anxiety And Depression In Patients With Moderate-To-Severe Plaque Psoriasis (PR Newswire)
15.02.18	AMAG Gets FDA Nod, ABMD Hits All-time High, GLMD's NAFLD Trial Flops, NKTR Abuzz (RTTNews)
14.02.18	Valeant's Ortho Dermatologics Says FDA Accepts NDA For IDP-122 Lotion (RTTNews)
14.02.18	Ortho Dermatologics Announces U.S. FDA Filing Acceptance For JEMDEL™ Plaque Psoriasis Treatment (PR Newswire)
14.02.18	Ortho Dermatologics Announces U.S. FDA Filing Acceptance For JEMDEL™ Plaque Psoriasis Treatment (PR Newswire)
12.02.18	Le ministre Brison dépose le Budget provisoire des dépenses 2018-2019, une étape importante de la réforme du budget des dépenses pour améliorer la reddition de comptes au Parlement et aux Canadiens (PR Newswire)
09.02.18	Salix Provides Update on FDA Submission for PLENVU®* (PR Newswire)
09.02.18	Salix Provides Update on FDA Submission for PLENVU®* (PR Newswire)
06.02.18	Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28 (PR Newswire)
06.02.18	Valeant Will Release Fourth-Quarter And Full-Year 2017 Financial Results On February 28 (PR Newswire)
29.01.18	Endo to Announce Fourth-Quarter 2017 Financial Results (PR Newswire)
26.01.18	Biotech Stocks Facing FDA Decision In February (RTTNews)
25.01.18	Valeant Will Reduce Debt By An Additional $200 Million (PR Newswire)
25.01.18	Valeant Will Reduce Debt By An Additional $200 Million (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Valeant Pharmaceuticals International Inc.

Aktien Top/Flop

Meistgelesene Nachrichten